Split History
PTIE split history picture
PTIE (PTIE) has 1 split in our PTIE split history database. The split for PTIE took place on May 10, 2017. This was a 1 for 7 reverse split, meaning for each 7 shares of PTIE owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 142.857142857143 share position following the split.

When a company such as PTIE conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the PTIE split history from start to finish, an original position size of 1000 shares would have turned into 142.857142857143 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into PTIE shares, starting with a $10,000 purchase of PTIE, presented on a split-history-adjusted basis factoring in the complete PTIE split history. PTIE split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 06/11/2013
End date: 03/27/2019
Start price/share: $17.50
End price/share: $1.24
Dividends collected/share: $0.00
Total return: -92.91%
Average Annual Total Return: -36.67%
Starting investment: $10,000.00
Ending investment: $708.63
Years: 5.79
Cassava Sciences engages in developing proprietary drugs for patients and healthcare professionals, and focuses its drug development efforts on disorders of the nervous system, such as chronic pain. Co.'s primary drug candidate, REMOXY, is a proprietary, abuse-deterrent, oral formulation of oxycodone developed to make oxycodone difficult to abuse yet provide pain relief. Co.'s other drug candidate, FENROCK, is a proprietary, abuse-deterrent skin patch to treat severe pain. In addition, Co. has worldwide rights to PTI-125, a small molecule drug candidate designed to treat Alzheimer's Disease and other neurological disorders. According to our PTIE split history records, PTIE has had 1 split.
Date Ratio
05/10/20171 for 7
PTIE is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

PTN Split History
PTX Split History
PULM Split History
PVCT Split History
Q Split History
QGEN Split History
QLTI Split History
RARE Split History
RCKT Split History
RCPI Split History

Also explore: PTIE shares outstanding history

Email EnvelopeFree PTIE Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Cineverse Corp. (CNVS)
Aptose Biosciences Inc. (APTO)
Greenlane Holdings, Inc. (GNLN)
Wheels Up Experience (UP)
Angion Biomedia Corp. (ANGN)
Troika Media Group, Inc. (TRKA)
Landos Biopharma, Inc. (LABP)
Healthcare Triangle, Inc. (HCTI)
LiqTech International, Inc. (LIQT)
Lordstown Motors Corp. (RIDE)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

PTIE Insider Buying

PTIE Split History | www.SplitHistory.com | Copyright © 2013 - 2023, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
Wait! Don't leave yet.
Want to receive our latest research absolutely free?

Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 7.8%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 7.8%.